Published in Nucleic Acids Res on July 25, 1990
Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest (1994) 1.42
Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22. J Clin Invest (1996) 0.99
Genetic mapping of the beta 1 GABA receptor gene to human chromosome 4, using a tetranucleotide repeat polymorphism. Am J Hum Genet (1991) 0.98
Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. Am J Hum Genet (1998) 0.91
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase with cDNA probes. Proc Natl Acad Sci U S A (1985) 5.33
Localization of the structural gene for human apolipoprotein A-I on the long arm of human chromosome 11. Proc Natl Acad Sci U S A (1984) 3.70
Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science (1996) 8.29
Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science (2000) 6.73
Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science (2001) 4.32
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest (1992) 3.05
Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics (1995) 2.94
Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet (1993) 2.70
High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med (2001) 2.61
Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest (1996) 2.04
Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. N Engl J Med (1987) 1.96
Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hypercholesterolemia. J Biol Chem (1986) 1.94
Common low-density lipoprotein receptor mutations in the French Canadian population. J Clin Invest (1990) 1.82
Polymorphic DNA haplotypes at the LDL receptor locus. Am J Hum Genet (1989) 1.82
Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest (1993) 1.69
Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest (1991) 1.68
A high frequency of length polymorphisms in repeated sequences adjacent to Alu sequences. Am J Hum Genet (1990) 1.67
Polymorphism and evolution of Alu sequences in the human low density lipoprotein receptor gene. Proc Natl Acad Sci U S A (1985) 1.63
Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J Biol Chem (1992) 1.45
Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners. J Clin Invest (1989) 1.45
Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a). Proc Natl Acad Sci U S A (1998) 1.38
Structure of the human gene encoding sterol regulatory element binding protein 2 (SREBF2). Genomics (1997) 1.34
AvaII polymorphism in the human LDL receptor gene. Nucleic Acids Res (1987) 1.33
Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1. J Biol Chem (1997) 1.23
Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J Biol Chem (1994) 1.22
The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans. Am J Hum Genet (1997) 1.17
Dinucleotide repeat polymorphism at the 3' end of the LDL receptor gene. Nucleic Acids Res (1990) 1.11
No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler Thromb Vasc Biol (1995) 1.10
Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. Clin Chem (1996) 1.10
Transport of lipids from high and low density lipoproteins via scavenger receptor-BI. J Biol Chem (1999) 1.10
Human LDL receptor gene: two ApaLI RFLPs. Nucleic Acids Res (1987) 1.09
Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia. Proc Natl Acad Sci U S A (1988) 1.08
Polyunsaturated fatty acids up-regulate hepatic scavenger receptor B1 (SR-BI) expression and HDL cholesteryl ester uptake in the hamster. J Lipid Res (1999) 1.08
Lipoprotein(a) and growth hormone: is the puzzle solved? Eur J Endocrinol (1997) 1.07
Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus. J Clin Invest (1994) 1.07
Scavenger receptor, class B, type I-dependent stimulation of cholesterol esterification by high density lipoproteins, low density lipoproteins, and nonlipoprotein cholesterol. J Biol Chem (1998) 1.05
Cloning of the human cholesterol 7 alpha-hydroxylase gene (CYP7) and localization to chromosome 8q11-q12. Genomics (1992) 1.04
Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Hum Mutat (2001) 1.02
Expression of the VLDL receptor in endothelial cells. Arterioscler Thromb Vasc Biol (1996) 0.97
Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels. J Clin Invest (1993) 0.96
Human LDL receptor gene: HincII polymorphism detected by gene amplification. Nucleic Acids Res (1988) 0.94
Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice. Arterioscler Thromb Vasc Biol (1995) 0.93
The LDL receptor in familial hypercholesterolemia: use of human mutations to dissect a membrane protein. Cold Spring Harb Symp Quant Biol (1986) 0.92
Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum Mol Genet (1995) 0.92
Developmental and hormonal regulation of murine scavenger receptor, class B, type 1. Mol Endocrinol (1999) 0.90
Expression of human apolipoprotein B100 in transgenic mice. Editing of human apolipoprotein B100 mRNA. J Biol Chem (1993) 0.90
Tetranucleotide repeat polymorphism in the LPL gene. Nucleic Acids Res (1990) 0.84
Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine. J Clin Invest (1996) 0.83
Transgenic mice expressing a human apolipoprotein[a] allele. J Lipid Res (1999) 0.83
Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein. J Biol Chem (1994) 0.82
Sequence diversity in genes of lipid metabolism. Genome Res (2001) 0.81
EcoN I polymorphism in the human cholesteryl ester transfer protein (CEPT) gene. Nucleic Acids Res (1990) 0.81
Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a). J Clin Invest (1996) 0.81
Molecular basis of familial hypercholesterolemia. Arteriosclerosis (1989) 0.81
Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse. J Lipid Res (1998) 0.80
Sequence microheterogeneity in apolipoprotein(a) gene repeats and the relationship to plasma Lp(a) levels. Hum Mol Genet (1995) 0.79
Molecular genetics of lipoprotein (a): new pieces to the puzzle. Curr Opin Lipidol (1994) 0.79
High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: implications for plasma Lp(a) assay. Clin Genet (1997) 0.78
Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction. Circulation (1993) 0.78
Determinants of human apolipoprotein [a] secretion from mouse hepatocyte cultures. J Lipid Res (2001) 0.77
Low density lipoprotein kinetics in a family having defective low density lipoprotein receptors in which hypercholesterolemia is suppressed. Arterioscler Thromb (1991) 0.77
Human growth hormone increases apo(a) expression in transgenic mice. Arterioscler Thromb Vasc Biol (1999) 0.77
CGG triple repeat polymorphism in VLDL receptor (VLDL-R) gene. Hum Mol Genet (1994) 0.75
Genetics and molecular biology. Curr Opin Lipidol (1995) 0.75
Tetranucleotide repeat polymorphism in the apolipoprotein B gene. Nucleic Acids Res (1990) 0.75
Tetranucleotide length polymorphism 5' of the alpha 2-macroglobulin receptor (A2MR)/LDL receptor-related protein (LRP) gene. Hum Mol Genet (1994) 0.75
Genetics and molecular biology. Curr Opin Lipidol (1994) 0.75
Crayfish in Southern Nevada. Science (1948) 0.75
1993 Aspen Cholesterol/Bile Acid Conference: diet and gene interactions in cholesterol metabolism. J Lipid Res (1994) 0.75
Genetic factors that contribute to interindividual variations in plasma low density lipoprotein-cholesterol levels. Ciba Found Symp (1996) 0.75